CUV 0.00% $13.96 clinuvel pharmaceuticals limited

Ann: Appendix 4C - quarterly, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 846 Posts.
    lightbulb Created with Sketch. 1164
    43% increase in revenue year on year not too bad considering US sales haven't started yet and there will still be more growth to come from Europe as more countries come online. The big revenue (and VERY profitable) quarters are still to come, 4 out of the next 7 quarters are the biggies.

    The shorters treat this company like it is going broke, it is not, it is very profitable and with US sales to start later this year it will become extremely profitable. What will the shorts do with all that growth to come? 22nd most shorted company what a joke, they are trying to sow fear when they should be fearful.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.